Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

WSFX Global Pay Q1 FY27: Revenue ₹1,491 Cr, PAT ₹0.30 Cr | Arthneeti

Q1 FY27

Gross Turnover (Q1 FY27): ₹1,491 Crore, up 36.24% YoY (Page 2, 6, 9) . Key investor presentation takeaways from WSFX Global Pay Ltd's Q1 FY27 investor presentation — and how it…

18 Oct 2026

Devson Catalyst Q1 FY27 investor presentation: Revenue & Margins | Arthneeti

Q1 FY27

FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector peers.

18 Oct 2026

Brahmaputra Infrastructure Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Current order book as of March 2026: INR 1,600 crores, equivalent to 4.46x FY26 revenue. Key concall takeaways from Brahmaputra Infrastructure Ltd's Q4 FY26…

18 Oct 2026

Brahmaputra Infrastructure Q1 FY27: Revenue ₹110.79 Cr | Arthneeti

Q1 FY27

Strong revenue growth:** Consolidated top line grew 20% YoY to ₹110.79 crore in Q1 FY27, marking the first ₹100+ crore quarter in 10 years. Key concall…

18 Oct 2026

Regency Fincorp Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Disbursements grew 43% YoY to INR 142 crores in FY2026. Key concall takeaways from Regency Fincorp's Q4 FY26 earnings call — and how it ranks against sector…

18 Oct 2026

Regency Fincorp Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

. Key concall takeaways from Regency Fincorp's Q1 FY27 earnings call — and how it ranks against sector peers.

18 Oct 2026

Rossari Biotech Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

H1 revenue grew 20% YoY, driven largely by volume growth rather than price increases (Page 9). Key concall takeaways from Rossari Biotech's Q2 FY27 earnings…

18 Oct 2026

Hero Motors Q2 FY27 investor presentation: Revenue & Margins | Arthneeti

Q2 FY27

Consolidated Revenue from Operations Q1-FY27:** ₹3,193 Mn, up 24.9% YoY from ₹2,557 Mn in Q1-FY26 . Key investor presentation takeaways from Hero Motors Ltd's Q2 FY27…

17 Oct 2026

Lagnam Spintex Q2 FY27 results statement: Revenue & Margins | Arthneeti

Q2 FY27

13,242.61 Lacs (approximate increase of 30.3%) . Key results statement takeaways from Lagnam Spintex's Q2 FY27 results statement — and how it ranks against sector peers.

17 Oct 2026

Bajaj Healthcare Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

FY27 Capex planned between INR 65 crores to INR 80 crores. Key concall takeaways from Bajaj Healthcare Ltd's Q2 FY27 earnings call — and how it ranks against…

17 Oct 2026

Parin Enterprises Q2 FY27 results statement: Revenue & Margins | Arthneeti

Q2 FY27

For the quarter ended 30 September 2026, consolidated revenue from operations was ₹8,643.27 lakhs. Key results statement takeaways from Parin Enterprises Ltd's Q2 FY27…

17 Oct 2026

Delaplex Q1 FY27 investor presentation: Revenue & Margins | Arthneeti

Q1 FY27

H2 FY26 total income (quarterly equivalent): ₹340.4 Mn vs ₹328.4 Mn in H2 FY25, a 3.66% YoY increase. Key investor presentation takeaways from Delaplex Ltd's Q1 FY27…

17 Oct 2026

IDBI Bank Q2 FY27 results statement: Revenue & Margins | Arthneeti

Q2 FY27

8,512.14 crore (up from Rs. Key results statement takeaways from IDBI Bank Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

17 Oct 2026

Rishi Laser Q1 FY27: Revenue ₹42.26 Cr, PAT ₹0.50 Cr | Arthneeti

Q1 FY27

Q1 FY27 Revenue: ₹42.26 Cr, up 2.99% YoY (from ₹41.03 Cr in Q1 FY26). Key investor presentation takeaways from Rishi Laser Ltd's Q1 FY27 investor presentation — and how it ranks…

17 Oct 2026

Apollo Finvest (India) Q1 FY27: Revenue ₹25.9 Cr, PAT ₹11.34 Cr | Arthneeti

Q1 FY27

The presentation reports **total income of ₹25.9 crore for Q1 FY27**, up from ₹21.6 crore in Q1 FY26, indicating a **year-on-year growth of 20%**. Key investor presentation…

17 Oct 2026

Himalaya Nutravedics India Q2 FY27 investor presentation: Revenue & Margins | Arthneeti

Q2 FY27

Reported revenue from operations for FY26: ₹4,306.8 lakhs, a year-on-year increase of 105.1% from ₹2,099.7 lakhs in FY25 (Page 22, 14, 5, 4). Key investor presentation…

17 Oct 2026

Yes Bank Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

With a pro forma CET-1 ratio of 11.4%, the bank believes growth ambitions are not compromised and can grow at approximately 11% without capital dilution…

17 Oct 2026

Punjab & Sind Bank Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Net interest income has grown by 22%, indicating improving margins. Key concall takeaways from Punjab & Sind Bank's Q2 FY27 earnings call — and how it ranks…

17 Oct 2026

Kross Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Capex of INR170 crores planned for seamless tube and expansion, supporting future capacity and volume growth. Key concall takeaways from Kross Ltd's Q2 FY27…

17 Oct 2026

India Cements Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Capital allocation includes INR1,800 crores capex for Ultravolt; ramp-up continues. Key concall takeaways from India Cements Ltd's Q2 FY27 earnings call — and…

17 Oct 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access